Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:RCOR

Renovacor (RCOR) Stock Price, News & Analysis

Renovacor logo

About Renovacor Stock (NYSE:RCOR)

Advanced Chart

Key Stats

Today's Range
$3.20
$3.20
50-Day Range
$2.56
$3.28
52-Week Range
$1.34
$9.74
Volume
N/A
Average Volume
30,033 shs
Market Capitalization
$55.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.

Receive RCOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renovacor and its competitors with MarketBeat's FREE daily newsletter.

RCOR Stock News Headlines

Renovacor, Inc. Common Stock (RCOR)
RBC Core Bond Pool ETF (RCOR)
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

RCOR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Renovacor investors own include HubSpot (HUBS), ForgeRock (FORG), Sportradar Group (SRAD), Thoughtworks (TWKS), Confluent (CFLT) and Netflix (NFLX).

Company Calendar

Today
6/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NYSE:RCOR
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.10 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.47 per share
Price / Book
1.30

Miscellaneous

Free Float
14,782,000
Market Cap
$55.26 million
Optionable
Not Optionable
Beta
-0.28
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:RCOR) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners